Abstract:Interleukin-33 (IL-33) and its receptor ST2 contribute to spinal glial activation and chronic pain. A recent study showed that peripheral IL-33 plays a pivotal role in the pathogenesis of chronic itch induced by poison ivy. However, how IL-33/ST2 signaling in the spinal cord potentially mediates chronic itch remains elusive. Here, we determined that St2-/- substantially reduced scratching behaviors in 2,4-dinitrofluorobenzene (DNFB)-induced allergic contact dermatitis (ACD) as well as acetone and diethylether followed by water-induced dry skin in mice. Intrathecal administration of the neutralizing anti-ST2 or anti-IL-33 antibody remarkably decreased the scratching response in DNFB-induced ACD mice. Expression of spinal IL-33 and ST2 significantly increased in ACD mice, as evidenced by increased mRNA and protein levels. Immunofluorescence and in situ hybridization demonstrated that increased expression of spinal IL-33 was predominant in oligodendrocytes and astrocytes, whereas ST2 was mainly expressed in astrocytes. Further studies showed that in ACD mice, the activation of astrocytes and increased phosphorylation of signal transducer and activator of transcription 3 (STAT3) were markedly attenuated by St2-/- . Intrathecal injection of Janus Kinase 2 Inhibitor AG490 significantly alleviated scratching behaviors in ACD mice. rIL-33 pretreatment exacerbated gastrin-releasing peptide (GRP)-evoked scratching behaviors. This increased gastrin-releasing peptide receptor (GRPR) expression was abolished by St2-/- . Tnf-α upregulation was suppressed by St2-/- . Our results indicate that the spinal IL-33/ST2 signaling pathway contributes to chronic itch via astrocytic JAK2-STAT3 cascade activation, promoting TNF-α release to regulate the GRP/GRPR signaling-related itch response. Thus, these findings provide a potential therapeutic option for treating chronic pruritus.

The Cytokine TGF-β Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

Cytokines and Chemokines Modulation of Itch

Dysregulation of T Lymphocyte Function in Itchy Mice: a Role for Itch in TH2 Differentiation

TLR3 Deficiency Impairs Spinal Cord Synaptic Transmission, Central Sensitization, and Pruritus in Mice.

A Spinal Neural Circuitry For Converting Touch To Itch Sensation

VGLUT2-dependent Glutamate Release from Nociceptors is Required to Sense Pain and Suppress Itch.

Toll-Like Receptor 4 Contributes to Chronic Itch, Alloknesis, and Spinal Astrocyte Activation in Male Mice

Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice

Mechanical and chemical itch regulated by neuropeptide Y-Y1 signaling

Spinal IL-33/ST2 Signaling Mediates Chronic Itch in Mice Through the Astrocytic JAK2-STAT3 Cascade

Neutrophil-derived oxidative stress contributes to skin inflammation and scratching in a mouse model of allergic contact dermatitis via triggering pro-inflammatory cytokine and pruritogen production in skin

A basophil-neuronal axis promotes itch

CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis

Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse

Miswiring of Merkel cell and pruriceptive C fiber drives the itch-scratch cycle

Microglia Are Involved in Pruritus Induced by DNFB Via the CX3CR1/p38 MAPK Pathway.

Aberrant Wound Healing in an Epidermal Interleukin-4 Transgenic Mouse Model of Atopic Dermatitis

Distinctively Expressed Cytokines by Three Different Inflammation Cells and Their Interaction with Keratinocytes in Wound Healing

IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis

IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing